Gnann, J. W. Jr & Whitley, R. J. Herpes simplex encephalitis: an update. Curr. Infect. Dis. Rep. 19, 13 (2017).
Google Scholar
Messacar, K., Fischer, M., Dominguez, S. R., Tyler, K. L. & Abzug, M. J. Encephalitis in US children. Infect. Dis. Clin. North. Am. 32, 145–162 (2018).
Google Scholar
Tyler, K. L. Acute viral encephalitis. N. Engl. J. Med. 379, 557–566 (2018).
Google Scholar
Smith, M. G., Lennette, E. H. & Reames, H. R. Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am. J. Pathol. 17, 55–68 (1941).
Google Scholar
Wolman, B. & Longson, M. Herpes encephalitis. Acta Paediatr. Scand. 66, 243–246 (1977).
Google Scholar
Wertheim, J. O., Smith, M. D., Smith, D. M., Scheffler, K. & Kosakovsky Pond, S. L. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol. Biol. Evol. 31, 2356–2364 (2014).
Google Scholar
Rathbun, M. M. & Szpara, M. L. A holistic perspective on herpes simplex virus (HSV) ecology and evolution. Adv. Virus Res. 110, 27–57 (2021).
Google Scholar
Wilson, T. M. et al. Fatal human alphaherpesvirus 1 infection in free-ranging black-tufted marmosets in anthropized environments, Brazil, 2012–2019. Emerg. Infect. Dis. 28, 802–811 (2022).
Google Scholar
Smith, G. Herpesvirus transport to the nervous system and back again. Annu. Rev. Microbiol. 66, 153–176 (2012).
Google Scholar
Swanson, P. A. 2nd & McGavern, D. B. Viral diseases of the central nervous system. Curr. Opin. Virol. 11, 44–54 (2015).
Google Scholar
Whitley, R. J. Herpes simplex virus infections of the central nervous system. Continuum 21, 1704–1713 (2015).
Google Scholar
Wang, H., Davido, D. J., Mostafa, H. H. & Morrison, L. A. Efficacy of an HSV-1 neuro-attenuated vaccine in mice is reduced by preventing viral DNA replication. Viruses 14, 869 (2022).
Google Scholar
Elion, G. B. The biochemistry and mechanism of action of acyclovir. J. Antimicrob. Chemother. 12, 9–17 (1983).
Google Scholar
Gnann, J. W. Jr, Barton, N. H. & Whitley, R. J. Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy 3, 275–283 (1983).
Google Scholar
Campbell, M., Klapper, P. E. & Longson, M. Acyclovir in herpes encephalitis. Lancet 1, 38 (1982).
Google Scholar
Stahl, J. P. & Mailles, A. Herpes simplex virus encephalitis update. Curr. Opin. Infect. Dis. 32, 239–243 (2019).
Google Scholar
Whitley, R. J., Gnann J. W. in The Humanherpesviruses (ed. Whitley, R. J., Roizman, B. & Lopez, C.) 69–105 (Raven Press, 1993).
Whitley, R. J. Herpes simplex virus in children. Curr. Treat. Options Neurol. 4, 231–237 (2002).
Google Scholar
Abel, L. et al. Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J. Pediatr. 157, 623–629 (2010). 629 e621.
Google Scholar
Whitley, R. J. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 71, 141–148 (2006).
Google Scholar
Jubelt, B., Mihai, C., Li, T. M. & Veerapaneni, P. Rhombencephalitis/brainstem encephalitis. Curr. Neurol. Neurosci. Rep. 11, 543–552 (2011).
Google Scholar
George, B. P., Schneider, E. B. & Venkatesan, A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. PLoS ONE 9, e104169 (2014).
Google Scholar
Hjalmarsson, A., Blomqvist, P. & Skoldenberg, B. Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin. Infect. Dis. 45, 875–880 (2007).
Google Scholar
Dagsdottir, H. M. et al. Herpes simplex encephalitis in Iceland 1987–2011. SpringerPlus 3, 524 (2014).
Google Scholar
Casanova, J. L. From second thoughts on the germ theory to a full-blown host theory. Proc. Natl Acad. Sci. USA 120, e2301186120 (2023).
Google Scholar
Casanova, J. L. & Abel, L. The microbe, the infection enigma, and the host. Annu. Rev. Microbiol. https://doi.org/10.1146/annurev-micro-092123-022855 (2024).
Casanova, J. L. & Abel, L. Lethal infectious diseases as inborn errors of immunity: toward a synthesis of the germ and genetic theories. Annu. Rev. Pathol. 16, 23–50 (2021).
Google Scholar
Tangye, S. G. & Latour, S. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. Blood 135, 644–655 (2020).
Google Scholar
Beziat, V., Casanova, J. L. & Jouanguy, E. Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis. Curr. Opin. Virol. 51, 9–15 (2021).
Google Scholar
Koskiniemi, M. et al. Familial herpes encephalitis. Lancet 346, 1553 (1995).
Google Scholar
Gazquez, I., Jover, A., Puig, T., Vincente de Vera, C. & Rubio, M. Familial herpes encephalitis. Lancet 347, 910 (1996).
Google Scholar
Jackson, A. C., Melanson, M. & Rossiter, J. P. Familial herpes simplex encephalitis. Ann. Neurol. 51, 406–407 (2002).
Google Scholar
Lerner, A. M., Levine, D. P. & Reyes, M. P. Two cases of herpes simplex virus encephalitis in the same family. N. Engl. J. Med. 308, 1481 (1983).
Google Scholar
Jouanguy, E. et al. Human inborn errors of immunity to herpes viruses. Curr. Opin. Immunol. 62, 106–122 (2020).
Google Scholar
Tangye, S. G. et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 42, 1473–1507 (2022).
Google Scholar
Bousfiha, A. et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J. Clin. Immunol. 42, 1508–1520 (2022).
Google Scholar
Dupuis, S. et al. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388–391 (2003). Autosomal recessive STAT1 deficiency was discovered in children with mycobacterial diseases and severe viral infections, including HSE in one child.
Google Scholar
Niehues, T. et al. A NEMO-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J. Allergy Clin. Immunol. 114, 1456–1462 (2004).
Google Scholar
Jouanguy, E. et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette–Guerin infection. N. Engl. J. Med. 335, 1956–1961 (1996).
Google Scholar
Dupuis, S. et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300–303 (2001).
Google Scholar
Chapgier, A. et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J. Immunol. 176, 5078–5083 (2006).
Google Scholar
Zhang, S. Y. et al. Inborn errors of RNA lariat metabolism in humans with brainstem viral infection. Cell 172, 952–965.e918 (2018). Biallelic variants of the DBR1 debranching enzyme impairing RNA lariat metabolism and antiviral immunity were discovered in children with HSV-1, IBV or norovirus infections of the brainstem.
Google Scholar
Lafaille, F. G. et al. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Nat. Med. 25, 1873–1884 (2019). Autosomal dominant deficiency of snoRNA31 was found to underlie forebrain HSE, revealing the role of snoRNA in antiviral defence.
Google Scholar
Le Voyer, T. et al. Genetic, immunological, and clinical features of 32 patients with autosomal recessive STAT1 deficiency. J. Immunol. 207, 133–152 (2021).
Google Scholar
Doffinger, R. et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat. Genet. 27, 277–285 (2001).
Google Scholar
Puel, A. et al. The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation. Am. J. Hum. Genet. 78, 691–701 (2006).
Google Scholar
Audry, M. et al. NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus. J. Allergy Clin. Immunol. 128, 610–617 (2011).
Google Scholar
Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308–312 (2006). UNC93B1 was the first human gene identified to confer a predisposition to isolated HSE.
Google Scholar
Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7, 156–164 (2006).
Google Scholar
Brinkmann, M. M. et al. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177, 265–275 (2007).
Google Scholar
Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007). Autosomal dominant TLR3 deficiency was identified in unrelated children with HSE, suggesting a role for defects of the UNC93B1-dependent TLR3 signalling pathway.
Google Scholar
Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076–2079 (2003).
Google Scholar
Ku, C. L. et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J. Med. Genet. 44, 16–23 (2007).
Google Scholar
von Bernuth, H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691–696 (2008).
Google Scholar
Picard, C. et al. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89, 403–425 (2010).
Google Scholar
Garcia-Garcia, A. et al. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. J. Exp. Med. 220, e20220170–2023.
Guo, Y. et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208, 2083–2098 (2011).
Google Scholar
Lim, H. K. et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology 83, 1888–1897 (2014).
Google Scholar
Armangue, T. et al. Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies. Brain 146, 4306–4319 (2023).
Google Scholar
Perez de Diego, R. et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33, 400–411 (2010). Autosomal dominant TRAF3 deficiency was found to impair TLR3 responsiveness in fibroblasts, used as a surrogate cell model, and to underlie HSE.
Google Scholar
Sancho-Shimizu, V. et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121, 4889–4902 (2011). Autosomal recessive and autosomal dominant TRIF deficiencies were identified in otherwise healthy children with HSE.
Google Scholar
Herman, M. et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209, 1567–1582 (2012). Autosomal dominant TBK1 deficiency impairs TLR3-mediated type I interferon production in fibroblasts and underlies HSE in unrelated children.
Google Scholar
Andersen, L. L. et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J. Exp. Med. 212, 1371–1379 (2015). Autosomal dominant IRF3 deficiency was identified in an otherwise healthy adolescent with HSE.
Google Scholar
Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144–1150 (2003).
Google Scholar
Yamamoto, M. et al. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).
Google Scholar
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161–167 (2003).
Google Scholar
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
Google Scholar
Hoebe, K. et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223–1229 (2003).
Google Scholar
Casanova, J. L., Abel, L. & Quintana-Murci, L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447–491 (2011).
Google Scholar
Hoebe, K. & Beutler, B. TRAF3: a new component of the TLR-signaling apparatus. Trends Mol. Med. 12, 187–189 (2006).
Google Scholar
Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208–211 (2006).
Google Scholar
Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207 (2006).
Google Scholar
Saha, S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257–3263 (2006).
Google Scholar
Pomerantz, J. L. & Baltimore, D. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18, 6694–6704 (1999).
Google Scholar
Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151 (2003).
Google Scholar
Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).
Google Scholar
Bibert, S. et al. Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase. Nat. Commun. 15, 3969 (2024).
Google Scholar
Lim, H. K. et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J. Exp. Med. 216, 2038–2056 (2019).
Google Scholar
Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).
Google Scholar
Zhang, Q., Bastard, P., Effort, C. H. G., Cobat, A. & Casanova, J. L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603, 587–598 (2022).
Google Scholar
Zhang, P. et al. A computational approach for detecting physiological homogeneity in the midst of genetic heterogeneity. Am. J. Hum. Genet. 108, 1012–1025 (2021).
Google Scholar
Uze, G., Lutfalla, G. & Gresser, I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225–234 (1990).
Google Scholar
Piehler, J., Thomas, C., Garcia, K. C. & Schreiber, G. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol. Rev. 250, 317–334 (2012).
Google Scholar
Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907–923 (2019).
Google Scholar
Bastard, P. et al. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency. J. Clin. Invest. 131, e139980 (2021). Autosomal recessive complete IFNAR1 deficiency was found in a child with HSE, establishing the crucial role of type I interferon immunity in defence against HSV-1 infection of the human brain.
Google Scholar
Hardy, M. P., Owczarek, C. M., Jermiin, L. S., Ejdeback, M. & Hertzog, P. J. Characterization of the type I interferon locus and identification of novel genes. Genomics 84, 331–345 (2004).
Google Scholar
Yazdani, R. et al. Candidiasis associated with very early onset inflammatory bowel disease: first IL10RB deficient case from the National Iranian Registry and review of the literature. Clin. Immunol. 205, 35–42 (2019).
Google Scholar
Korol, C. B. et al. Fulminant viral hepatitis in two siblings with inherited IL-10RB deficiency. J. Clin. Immunol. 43, 406–420 (2023).
Google Scholar
Meyts, I. & Casanova, J. L. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur. J. Immunol. 51, 1039–1061 (2021).
Google Scholar
Bastard, P. et al. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes. J. Exp. Med. 219, e20220028 (2022).
Google Scholar
Duncan, C. J. A. et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J. Exp. Med. 219, e20212427 (2022).
Google Scholar
Ogishi, M. et al. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. J. Exp. Med. 219, e20220094 (2022).
Google Scholar
Bucciol, G. et al. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases. J. Clin. Invest. 133, e168321 (2023).
Google Scholar
Garcia-Morato, M. B. et al. Impaired control of multiple viral infections in a family with complete IRF9 deficiency. J. Allergy Clin. Immunol. 144, 309–312.e10.
Hernandez, N. et al. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. J. Exp. Med. 215, 2567–2585 (2018).
Google Scholar
Bastard, P. et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J. Exp. Med. 218, e20202486 (2021).
Google Scholar
Liu, H., Qiu, K., He, Q., Lei, Q. & Lu, W. Mechanisms of blood–brain barrier disruption in herpes simplex encephalitis. J. Neuroimmune Pharmacol. 14, 157–172 (2019).
Google Scholar
Jacquemont, B. & Roizman, B. RNA synthesis in cells infected with herpes simplex virus: analysis of high molecular weight and symmetrical viral transcripts in herpesvirus infected cells. IARC Sci. Publ. 11, 39–48 (1975).
Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R. & Paludan, S. R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059–5064 (2006).
Google Scholar
Hochrein, H. et al. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl Acad. Sci. USA 101, 11416–11421 (2004).
Google Scholar
Yum, S., Li, M., Fang, Y. & Chen, Z. J. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections. Proc. Natl Acad. Sci. USA 118, e2100225118 (2021).
Google Scholar
Chiang, J. J. et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat. Immunol. 19, 53–62 (2018).
Google Scholar
Naesens, L. et al. GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141. Sci. Immunol. 7, eabq4531 (2022). Autosomal recessive TFIIIA deficiency impairs RIG-I-mediated type I interferon production during HSV-1 infection, thereby underlying HSE.
Google Scholar
Casanova, J. L., Abel, L. & Quintana-Murci, l. Immunology taught by human genetics. Cold Spring Harb. Symp. Quant. Biol. 78, 157–172 (2013).
Google Scholar
Casanova, J. L. & Abel, L. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202, 197–201 (2005).
Google Scholar
Casanova, J. L. & Abel, L. Primary immunodeficiencies: a field in its infancy. Science 317, 617–619 (2007).
Google Scholar
Casanova, J. L. & Abel, L. The genetic theory of infectious diseases: brief history and selected illustrations. Annu. Rev. Genomics Hum. Genet. 14, 215–243 (2013).
Google Scholar
Zhang, S. Y. et al. TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 25, 19–33 (2013).
Google Scholar
Lafaille, F. G. et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491, 769–773 (2012). Human TLR3- or UNC93B1-deficient patient-specific induced pluripotent stem cell-derived cortical neurons and oligodendrocytes were much more susceptible to HSV-1 than control cells, suggesting that TLR3–IFNα/β-mediated cortical neuron- and oligodendrocyte-autonomous anti-HSV-1 immunity is crucial for host defence against HSV-1 in the human forebrain.
Google Scholar
Zimmer, B. et al. Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection. Proc. Natl Acad. Sci. USA 115, E8775–E8782 (2018).
Google Scholar
Chiaradia, I. & Lancaster, M. A. Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo. Nat. Neurosci. 23, 1496–1508 (2020).
Google Scholar
Fan, W., Christian, K. M., Song, H. & Ming, G. L. Applications of brain organoids for infectious diseases. J. Mol. Biol. 434, 167243 (2022).
Google Scholar
Gao, D. et al. TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons. J. Clin. Invest. 131, e134529 (2021). This study demonstrated that TLR3 restricts viral growth in human fibroblasts and cortical neurons in vitro, through the basal IFNβ immunity-mediated control of early viral infection rather than the virus recognition-triggered amplification of IFNα/β production.
Google Scholar
Cavassani, K. A. et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609–2621 (2008).
Google Scholar
Bernard, J. J. et al. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat. Med. 18, 1286–1290 (2012).
Google Scholar
Kim, D. et al. Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3. Nat. Commun. 10, 2811 (2019).
Google Scholar
Bsibsi, M. et al. The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J. Immunol. 184, 6929–6937 (2010).
Google Scholar
Gollmann-Tepekoylu, C. et al. Toll-like receptor 3 mediates aortic stenosis through a conserved mechanism of calcification. Circulation 147, 1518–1533 (2023).
Google Scholar
Paludan, S. R. & Mogensen, T. H. Constitutive and latent immune mechanisms exert ‘silent’ control of virus infections in the central nervous system. Curr. Opin. Immunol. 72, 158–166 (2021).
Google Scholar
Paludan, S. R., Pradeu, T., Masters, S. L. & Mogensen, T. H. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137–150 (2021).
Google Scholar
Dorrity, T. J. et al. Long 3′UTRs predispose neurons to inflammation by promoting immunostimulatory double-stranded RNA formation. Sci. Immunol. 8, eadg2979 (2023).
Google Scholar
Ma, Z., Ni, G. & Damania, B. Innate sensing of DNA virus genomes. Annu. Rev. Virol. 5, 341–362 (2018).
Google Scholar
Liu, Z. et al. Encephalitis and poor neuronal death-mediated control of herpes simplex virus in human inherited RIPK3 deficiency. Sci Immunol 8, eade2860 (2023). Autosomal recessive RIPK3 deficiency confers a predisposition to HSE by impairing the cell death-dependent control of HSV-1 in cortical neurons independently of type I interferon immunity, providing proof of the principle that RIPK3-dependent cell death-mediated antiviral immunity is non-redundant.
Google Scholar
Yu, P. W. et al. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFκB. Curr. Biol. 9, 539–542 (1999).
Google Scholar
He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100–1111 (2009).
Google Scholar
Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1–RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–1123 (2009).
Google Scholar
Newton, K. RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol. 25, 347–353 (2015).
Google Scholar
Huang, Z. et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17, 229–242 (2015).
Google Scholar
Nogusa, S. et al. RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe 20, 13–24 (2016).
Google Scholar
Jorjani, H. et al. An updated human snoRNAome. Nucleic Acids Res. 44, 5068–5082 (2016).
Google Scholar
Kiss, A. M. Human Box H/ACA pseudouridylation guide RNA machinery. Mol. Cell. Biol. 24, 11 (2004).
Google Scholar
Jenkinson, E. M. et al. Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts. Nat. Genet. 48, 1185–1192 (2016).
Google Scholar
Chan, Y. H. et al. SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency. J. Exp. Med. 221, e20231725 (2024).
Google Scholar
Arenas, J. & Hurwitz, J. Purification of a RNA debranching activity from HeLa cells. J. Biol. Chem. 262, 4274–4279 (1987).
Google Scholar
Ruskin, B. & Green, M. R. An RNA processing activity that debranches RNA lariats. Science 229, 135–140 (1985).
Google Scholar
Nam, K., Lee, G., Trambley, J., Devine, S. E. & Boeke, J. D. Severe growth defect in a Schizosaccharomyces pombe mutant defective in intron lariat degradation. Mol. Cell. Biol. 17, 809–818 (1997).
Google Scholar
Chapman, K. B. & Boeke, J. D. Isolation and characterization of the gene encoding yeast debranching enzyme. Cell 65, 483–492 (1991).
Google Scholar
Nam, K. et al. Yeast lariat debranching enzyme. Substrate and sequence specificity. J. Biol. Chem. 269, 20613–20621 (1994).
Google Scholar
Jacquier, A. & Rosbash, M. RNA splicing and intron turnover are greatly diminished by a mutant yeast branch point. Proc. Natl Acad. Sci. USA 83, 5835–5839 (1986).
Google Scholar
Shamseldin, H. E. et al. A founder DBR1 variant causes a lethal form of congenital ichthyosis. Hum. Genet. 142, 1491–1498 (2023).
Google Scholar
Ru, S. et al. Human DBR1 deficiency impairs stress granule-dependent PKR antiviral immunity. J. Exp. Med. https://doi.org/10.1084/jem.20240010 (2024).
Ooi, S. L., Samarsky, D. A., Fournier, M. J. & Boeke, J. D. Intronic snoRNA biosynthesis in Saccharomyces cerevisiae depends on the lariat-debranching enzyme: intron length effects and activity of a precursor snoRNA. RNA 4, 1096–1110 (1998).
Google Scholar
Murray, J. L., Sheng, J. & Rubin, D. H. A role for H/ACA and C/D small nucleolar RNAs in viral replication. Mol. Biotechnol. 56, 429–437 (2014).
Google Scholar
Sedger, L. M. microRNA control of interferons and interferon induced anti-viral activity. Mol. Immunol. 56, 781–793 (2013).
Google Scholar
Han, B. et al. Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development. Oncogene 36, 5382–5391 (2017).
Google Scholar
Ulfendahl, P. J., Kreivi, J. P. & Akusjarvi, G. Role of the branch site/3′-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5′- and 3′-splice site co-operation. Nucleic Acids Res. 17, 925–938 (1989).
Google Scholar
Plotch, S. J. & Krug, R. M. In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: possible mechanisms for the control of viral mRNA splicing. Proc. Natl Acad. Sci. USA 83, 5444–5448 (1986).
Google Scholar
Perng, G. C. & Jones, C. Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip. Perspect. Infect. Dis. https://doi.org/10.1155/2010/262415 (2010).
Galvis, A. E., Fisher, H. E., Fan, H. & Camerini, D. Conformational changes in the 5′ end of the HIV-1 genome dependent on the debranching enzyme DBR1 during early stages of infection. J. Virol. 91, e01377-17 (2017).
Google Scholar
Chan, Y. H. et al. Human TMEFF1 is a restriction factor for herpes simplex virus in the brain. Nature 632, 390–400 (2024). The characterization of autosomal recessive TMEFF1 deficiency in two children with HSE revealed a new mechanism of HSV-1-specific cell-intrinsic antiviral immunity of the human brain.
Google Scholar
Eib, D. W. & Martens, G. J. A novel transmembrane protein with epidermal growth factor and follistatin domains expressed in the hypothalamo–hypophysial axis of Xenopus laevis. J. Neurochem. 67, 1047–1055 (1996).
Google Scholar
Morais da Silva, S., Gates, P. B., Eib, D. W., Martens, G. J. & Brockes, J. P. The expression pattern of tomoregulin-1 in urodele limb regeneration and mouse limb development. Mech. Dev. 104, 125–128 (2001).
Google Scholar
Eib, D. W. et al. Expression of the follistatin/EGF-containing transmembrane protein M7365 (tomoregulin-1) during mouse development. Mech. Dev. 97, 167–171 (2000).
Google Scholar
Dai, Y. et al. TMEFF1 is a neuron-specific restriction factor for herpes simplex virus. Nature 632, 383–389 (2024). Human cell line in vitro and mouse in vivo studies provided further evidence that TMEFF1 is a HSV-1 restriction factor in neurons.
Google Scholar
Connolly, S. A., Jackson, J. O., Jardetzky, T. S. & Longnecker, R. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9, 369–381 (2011).
Google Scholar
Rajbhandari, L. et al. Nectin-1 is an entry mediator for varicella-zoster virus infection of human neurons. J. Virol. 95, e0122721 (2021).
Google Scholar
Casanova, J. L. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl Acad. Sci. USA 112, E7128–7137 (2015).
Google Scholar
Puel, A., Bastard, P., Bustamante, J. & Casanova, J. L. Human autoantibodies underlying infectious diseases. J. Exp. Med. 219, e20211387 (2022).
Google Scholar
Gervais, A. et al. Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in approximately 40% of patients. J. Exp. Med. 220, e20230661 (2023). Autoantibodies against type I interferons were found to underlie WNV encephalitis in 40% of the patients studied, making WNV encephalitis the best understood infectious disease to date.
Google Scholar
Gervais, A. et al. Auto-Abs neutraliing type I IFNs underlie severe tick-borne encephalitis in ~10% of patients. J. Exp. Med. 221, e20240637 (2024).
Google Scholar
Solomon, T. Flavivirus encephalitis. N. Engl. J. Med. 351, 370–378 (2004).
Google Scholar
Abel, L. & Casanova, J. L. Human determinants of age-dependent patterns of infectious death. Immunity 57, 1457–1465 (2024).
Google Scholar
Bibert, S. et al. Herpes simplex encephalitis in adult patients with MASP-2 deficiency. PLoS Pathog. 15, e1008168 (2019).
Google Scholar
Hait, A. S. et al. Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. Sci. Immunol. 5, eabc2691 (2020).
Google Scholar
Casanova, J. L. et al. The ouroboros of autoimmunity. Nat. Immunol. 25, 743–754 (2024).
Google Scholar
Chen, J. et al. Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis. J. Exp. Med. 218, e20211349 (2021).
Google Scholar
Ogunjimi, B. et al. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Invest. 127, 3543–3556 (2017).
Google Scholar
Daza-Cajigal, V. et al. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria. Front. Immunol. 13, 888427 (2022).
Google Scholar
Casanova, J. L. & Abel, L. From rare disorders of immunity to common determinants of infection: following the mechanistic thread. Cell 185, 3086–3103 (2022).
Google Scholar
Zhang, S. Y. et al. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr. Opin. Immunol. 59, 88–100 (2019).
Google Scholar
Casanova, J. L. & Abel, L. Mechanisms of viral inflammation and disease in humans. Science 374, 1080–1086 (2021).
Google Scholar
Nathan, C. Rethinking immunology. Science 373, 276–277 (2021).
Gaudet, R. G. et al. A human apolipoprotein L with detergent-like activity kills intracellular pathogens. Science 373, eabf8113 (2021).
Zhang, S. Y., Harschnitz, O., Studer, L. & Casanova, J. L. Neuron-intrinsic immunity to viruses in mice and humans. Curr. Opin. Immunol. 72, 309–317 (2021).
Google Scholar
Bastard, P. et al. Interferon-β therapy in a patient with incontinentia pigmenti and autoantibodies against type I IFNs infected with SARS-CoV-2. J. Clin. Immunol. 41, 931–933 (2021).
Google Scholar
Wang, N. et al. Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients. Cell Host Microbe 28, 455–464.e452 (2020).
Google Scholar
Pereda, R. et al. Therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery. J. Interferon Cytokine Res. 40, 578–588 (2020).
Google Scholar
Mancini, M. & Vidal, S. M. Insights into the pathogenesis of herpes simplex encephalitis from mouse models. Mamm. Genome 29, 425–445 (2018).
Google Scholar
Wang, J. P. et al. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J. Virol. 86, 2273–2281 (2012).
Google Scholar
Sancho-Shimizu, V. et al. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr. Opin. Allergy Clin. Immunol. 7, 495–505 (2007).
Google Scholar
Lopez, C. Genetics of natural resistance to herpesvirus infections in mice. Nature 258, 152–153 (1975).
Google Scholar
Lopez, C. Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci. Immunogenetics 11, 87–92 (1980).
Google Scholar
Cantin, E., Tanamachi, B., Openshaw, H., Mann, J. & Clarke, K. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice. J. Virol. 73, 5196–5200 (1999).
Google Scholar
Sato, R. et al. Combating herpesvirus encephalitis by potentiating a TLR3–mTORC2 axis. Nat. Immunol. 19, 1071–1082 (2018).
Google Scholar
Reinert, L. S. et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122, 1368–1376 (2012).
Google Scholar
Orvedahl, A. & Levine, B. Autophagy and viral neurovirulence. Cell Microbiol. 10, 1747–1756 (2008).
Google Scholar
Yordy, B., Iijima, N., Huttner, A., Leib, D. & Iwasaki, A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12, 334–345 (2012).
Google Scholar
Katzenell, S. & Leib, D. A. Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons. J. Virol. 90, 4706–4719 (2016).
Google Scholar
